Patent · US Active

2,5-substituted pyrimidines

US9315490B2 · kind B2 · utility

2Cited by

0References

13Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Ingo Konetzki · Warthausen, DE
Tobias Craan · Niedernberg, DE
Florian Jakob · Aachen, DE
Antonio Nardi · Gambellara, IT
Christian Hesslinger · Zoznegg, DE
André WELBERS · Cologne, DE

Key dates

Filing date	Jul 15, 2015
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Jul 15, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/506
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel substituted condensed pyrimidine compounds of general formula (I)in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.